Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.28 USD | +2.62% | +9.56% | +76.21% |
04-29 | Leerink Partners Starts Neurogene With Outperform Rating, $46 Price Target | MT |
03-22 | North American Morning Briefing : Stocks Struggle After New Records | DJ |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- NGNE Stock
- Revisions Neurogene Inc.